What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Diffuse Large B-Cell Lymphoma

Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Ms Robin Klebig and Dr Matthew Lunning, including the following topics: Introduction (0:00) POLARIX: Polatuzumab Vedotin/R-CHP for Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (5:55) Polatuzumab Vedotin/Bendamustine/Rituximab and Selinexor for Relapsed Disease (24:28) CD19-Directed Antibody-Drug Conjugate Loncastuximab Tesirine (42:43) CD19-Directed Monoclonal Antibody Tafasitamab Combined with Lenalidomide (51:16) CD20 x CD3 Bispecific Antibodies (1:01:02) CAR (Chimeric Antigen Receptor) T-Cell Therapy (1:19:07) NCPD information and select publications

Om Podcasten

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.